Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.

[1]  M. Humbert,et al.  Pulmonary microvascular lesions regress in reperfused chronic thromboembolic pulmonary hypertension. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  M. Humbert,et al.  Right ventricular plasticity in a porcine model of chronic pressure overload. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  E. Fadel,et al.  Piglet Model of Chronic Pulmonary Hypertension , 2013, Pulmonary circulation.

[4]  P. Fawcett,et al.  Chronic carvedilol treatment partially reverses the right ventricular failure transcriptional profile in experimental pulmonary hypertension. , 2013, Physiological genomics.

[5]  H. Ghofrani,et al.  Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension: Results of the Randomized IMPRES Study , 2013, Circulation.

[6]  M. L. Handoko,et al.  Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe? , 2013, American journal of respiratory and critical care medicine.

[7]  M. Humbert,et al.  A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents. , 2012, American journal of respiratory and critical care medicine.

[8]  W. Paulus,et al.  Bisoprolol Delays Progression Towards Right Heart Failure in Experimental Pulmonary Hypertension , 2012, Circulation. Heart failure.

[9]  T. Branishte,et al.  The use of beta blocker Nebivolol in patients with chronic obstructive pulmonary disease in association with arterial hypertension. , 2012, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi.

[10]  P. Delafontaine,et al.  The effect of nebivolol versus metoprolol succinate extended release on asymmetric dimethylarginine in hypertension. , 2011, Journal of the American Society of Hypertension : JASH.

[11]  N. Voelkel,et al.  Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats. , 2010, American journal of respiratory and critical care medicine.

[12]  M. Humbert,et al.  Dexamethasone reverses monocrotaline-induced pulmonary arterial hypertension in rats , 2010, European Respiratory Journal.

[13]  MarcHumbert,et al.  Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era , 2010 .

[14]  M. Metra,et al.  Nebivolol , 2010 .

[15]  Kurt R Stenmark,et al.  Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[16]  T. Münzel,et al.  Nebivolol: the somewhat-different beta-adrenergic receptor blocker. , 2009, Journal of the American College of Cardiology.

[17]  M. Humbert,et al.  Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension. , 2008, Vascular pharmacology.

[18]  M. Humbert,et al.  Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. , 2008, American journal of respiratory and critical care medicine.

[19]  R. Naeije,et al.  Modèles animaux d'hypertension artérielle pulmonaire. , 2007 .

[20]  R. Naeije,et al.  [Animal models of pulmonary arterial hypertension]. , 2007, Revue des maladies respiratoires.

[21]  C. Ricachinevsky,et al.  Treatment of pulmonary arterial hypertension. , 2006, Jornal de pediatria.

[22]  M. Humbert,et al.  Angiopoietin/Tie2 pathway influences smooth muscle hyperplasia in idiopathic pulmonary hypertension. , 2006, American journal of respiratory and critical care medicine.

[23]  M. Humbert,et al.  Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia. , 2006, Circulation.

[24]  R. Brandes,et al.  Nebivolol Inhibits Superoxide Formation by NADPH Oxidase and Endothelial Dysfunction in Angiotensin II–Treated Rats , 2006, Hypertension.

[25]  J. Ryan,et al.  Autocrine actions of macrophage-derived catecholamines on interleukin-1β , 2005, Journal of Neuroimmunology.